Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter ( SGLT ) 2 inhibitor, with an IC 50 of 2.26 nM, about 1765-fold selectivity over SGLT1 ( IC 50 , 3990 nM). Luseogliflozin has the protential for researching type 2 diabetes.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。